drugset / Trial / NCT01683760

Pharmacokinetic Study of Fluconazole in Premature Infants

NCT01683760

Phase 2 Completed 80 enrolled Seoul National University Hospital
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to investigate the pharmacokinetics of fluconazole which is used as prophylaxis of invasive fungal infection in premature infants.

Timeline

Start
2012-09
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluconazole Small molecule 3 mg/kg Intravenous

Indications

No indication recorded.